Literature DB >> 21294217

Characterization of acetaminophen overdose-related emergency department visits and hospitalizations in the United States.

Angelika D Manthripragada1, Esther H Zhou, Daniel S Budnitz, Maribeth C Lovegrove, Mary E Willy.   

Abstract

PURPOSE: To estimate the number of acetaminophen overdose-related emergency department (ED) visits and hospitalizations in the United States, characterize these by intentionality, age, and gender, and compare the strengths and limitations of the utilized databases.
METHODS: We used data from the National Hospital Ambulatory Medical Care Survey (NHAMCS) and the National Electronic Injury Surveillance System (NEISS) to estimate the number of relevant ED visits in the United States between 2000 and 2007, and the National Hospital Discharge Survey (NHDS) to estimate the number of relevant hospitalizations in the United States between 1991 and 2006. National estimates and their standard errors were calculated using information provided in each database. We used the standard United States population in 2000 to calculate age-adjusted rates.
RESULTS: We estimate an annual average of 44,348 (NHAMCS, 2000-2007) or 78,414 (NEISS, 2006-2007) acetaminophen overdose-related ED visits and 33,520 (NHDS, 2000-2006) hospitalizations. For 2000-2006 we calculated an age-adjusted rate of 13.9 acetaminophen overdose-related hospitalizations per 100,000 US population, with the highest rate (15.7) occurring from 2005 to 2006. Between 1991 and 2006, there was no decrease noted in hospitalizations for intentional or unintentional overdoses. The majority of overdoses reported in NEISS (69.8%) and NHDS (74.2%) were classified as intentional (suicides or suicidal gestures), whereas in NHAMCS, intentionality was evenly distributed.
CONCLUSIONS: Our results suggest that acetaminophen overdose, both intentional and unintentional, remains a significant public health concern. With an understanding of their methodological characteristics and limitations, these national databases can be useful tools to characterize acetaminophen overdose-related ED visits and hospitalizations. Published in 2011 by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21294217     DOI: 10.1002/pds.2090

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  31 in total

1.  Trends in hepatic injury associated with unintentional overdose of paracetamol (Acetaminophen) in products with and without opioid: an analysis using the National Poison Data System of the American Association of Poison Control Centers, 2000-7.

Authors:  G Randall Bond; Mona Ho; Randall W Woodward
Journal:  Drug Saf       Date:  2012-02-01       Impact factor: 5.606

2.  Analgesic-Related Medication Errors Reported to US Poison Control Centers.

Authors:  Madhulika Eluri; Henry A Spiller; Marcel J Casavant; Thitphalak Chounthirath; Kristen A Conner; Gary A Smith
Journal:  Pain Med       Date:  2018-12-01       Impact factor: 3.750

3.  Effect of excipients on acetaminophen metabolism and its implications for prevention of liver injury.

Authors:  Michael Ganetsky; Mark Böhlke; Luis Pereira; David Williams; Barbara LeDuc; Shiva Guatam; Steven D Salhanick
Journal:  J Clin Pharmacol       Date:  2013-02-22       Impact factor: 3.126

4.  Blood gene expression profiling of an early acetaminophen response.

Authors:  P R Bushel; R D Fannin; K Gerrish; P B Watkins; R S Paules
Journal:  Pharmacogenomics J       Date:  2016-03-01       Impact factor: 3.550

Review 5.  Role and mechanisms of autophagy in acetaminophen-induced liver injury.

Authors:  Xiaojuan Chao; Hua Wang; Hartmut Jaeschke; Wen-Xing Ding
Journal:  Liver Int       Date:  2018-05-14       Impact factor: 5.828

Review 6.  Liver Regeneration after Acetaminophen Hepatotoxicity: Mechanisms and Therapeutic Opportunities.

Authors:  Bharat Bhushan; Udayan Apte
Journal:  Am J Pathol       Date:  2019-01-14       Impact factor: 4.307

7.  Risk of unintentional overdose with non-prescription acetaminophen products.

Authors:  Michael S Wolf; Jennifer King; Kara Jacobson; Lorenzo Di Francesco; Stacy Cooper Bailey; Rebecca Mullen; Danielle McCarthy; Marina Serper; Terry C Davis; Ruth M Parker
Journal:  J Gen Intern Med       Date:  2012-05-26       Impact factor: 5.128

8.  Editor's Highlight: Metformin Protects Against Acetaminophen Hepatotoxicity by Attenuation of Mitochondrial Oxidant Stress and Dysfunction.

Authors:  Kuo Du; Anup Ramachandran; James L Weemhoff; Hemantkumar Chavan; Yuchao Xie; Partha Krishnamurthy; Hartmut Jaeschke
Journal:  Toxicol Sci       Date:  2016-08-25       Impact factor: 4.849

9.  Lower susceptibility of female mice to acetaminophen hepatotoxicity: Role of mitochondrial glutathione, oxidant stress and c-jun N-terminal kinase.

Authors:  Kuo Du; C David Williams; Mitchell R McGill; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2014-09-16       Impact factor: 4.219

Review 10.  Biomarkers of drug-induced liver injury: progress and utility in research, medicine, and regulation.

Authors:  Mitchell R McGill; Hartmut Jaeschke
Journal:  Expert Rev Mol Diagn       Date:  2018-08-13       Impact factor: 5.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.